MP26-12 USE OF THE MYPROSTATESCORE (MPS) TEST FOR RISK STRATIFICATION IN MEN WITH A PREVIOUS NEGATIVE BIOPSY: INITIAL VALIDATION OF A STRAIGHTFORWARD TESTING APPROACH
2021
INTRODUCTION AND OBJECTIVE:The MyProstateScore (MPS) test incorporates prostate cancer antigen 3 (PCA3) and the TMPRSS2:ERG gene fusion (T2:ERG) with serum PSA to better define risk of Grade Group ...
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI